Skip to main
ADUS

Addus HomeCare (ADUS) Stock Forecast & Price Target

Addus HomeCare (ADUS) Analyst Ratings

Based on 9 analyst ratings
Buy
Strong Buy 22%
Buy 56%
Hold 11%
Sell 11%
Strong Sell 0%

Bulls say

Addus HomeCare Corp is showing robust organic revenue growth, with the personal care segment achieving a notable 12.3% year-over-year increase in 2023, and maintaining a positive trajectory with projected growth rates of 7.7% in 2024 and 7.4% year-to-date in 2025. The recent 2.6% Medicare Hospice rate increase effective October 2025 is expected to bolster growth in the hospice segment, which is transitioning to a stable growth phase characterized by low-single-digit rate updates and additional revenue from operational improvements and mergers and acquisitions. The combination of a supportive reimbursement environment, strong fundamentals in the personal care segment, and strategic growth opportunities positions Addus HomeCare favorably for continued financial performance.

Bears say

Addus HomeCare has experienced same-store declines in 2025 year-to-date due to challenges posed by Medicaid redeterminations, resulting in administrative bottlenecks that hinder the onboarding of new patients and lead to higher discharge rates. Approximately 97% of the company's segment revenues are at risk due to ongoing uncertainties surrounding the future Medicaid funding environment, particularly related to the One Big Beautiful Bill Act (OBBBA). While the company maintains a seemingly favorable long-term demand backdrop, the disconnect between its equity performance and broader market dynamics raises concerns about its stability and future growth potential.

Addus HomeCare (ADUS) has been analyzed by 9 analysts, with a consensus rating of Buy. 22% of analysts recommend a Strong Buy, 56% recommend Buy, 11% suggest Holding, 11% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Addus HomeCare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Addus HomeCare (ADUS) Forecast

Analysts have given Addus HomeCare (ADUS) a Buy based on their latest research and market trends.

According to 9 analysts, Addus HomeCare (ADUS) has a Buy consensus rating as of Dec 25, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $137.11, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $137.11, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Addus HomeCare (ADUS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.